product summary
company name :
Cell Signaling Technology
product type :
antibody
product name :
SMYD2 (D14H7) Rabbit mAb
catalog :
9734
clonality :
monoclonal
host :
rabbit
conjugate :
nonconjugated
clone name :
D14H7
reactivity :
human, mouse, rat, dog, cow
application :
western blot, immunoprecipitation
citations: 4
Published Application/Species/Sample/DilutionReference
  • western blot; human; 1:1000; loading ...; fig 2a
Wang R, Deng X, Yoshioka Y, Vougiouklakis T, Park J, Suzuki T, et al. Effects of SMYD2-mediated EML4-ALK methylation on the signaling pathway and growth in non-small-cell lung cancer cells. Cancer Sci. 2017;108:1203-1209 pubmed publisher
  • western blot; human; loading ...; fig 1a
Olsen J, Cao X, Han B, Chen L, Horvath A, Richardson T, et al. Quantitative Profiling of the Activity of Protein Lysine Methyltransferase SMYD2 Using SILAC-Based Proteomics. Mol Cell Proteomics. 2016;15:892-905 pubmed publisher
Li L, Fan L, Zhou J, Grantham J, Calvet J, Sage J, et al. Lysine methyltransferase SMYD2 promotes cyst growth in autosomal dominant polycystic kidney disease. J Clin Invest. 2017;127:2751-2764 pubmed publisher
Nakakido M, Deng Z, Suzuki T, Dohmae N, Nakamura Y, Hamamoto R. Dysregulation of AKT Pathway by SMYD2-Mediated Lysine Methylation on PTEN. Neoplasia. 2015;17:367-73 pubmed publisher
product information
SKU :
9734S
Product-Name :
SMYD2 (D14H7) Rabbit mAb
Size :
100 ul
Price-(USD) :
235 USD
Species-x-Reactivity :
H, M, R, Mk, (Hm, B, Dg, Hr)
Applications :
Immunoprecipitation
Product-Category :
Chromatin Regulation / Nuclear Function
Shipping-Temp :
AMBIENT
Storage-Temp :
-20°C
Product-Type :
Monoclonal Antibody
MW :
49
Host :
Rabbit
Target :
SMYD2
Primary-Protein :
SMYD2
Alt-Names :
HSKM-B,KMT3C,Lysine N-methyltransferase 3C,MGC119305,SET and MYND domain containing 2,SET and MYND domain-containing protein 2,SMYD2,ZMYND14,zinc finger, MYND domain containing 14
company information
Cell Signaling Technology
3 Trask Lane
Danvers, MA 01923
info@cellsignal.com
www.cellsignal.com
8776162355
headquarters: USA
Established in Beverly, MA in 1999, Cell Signaling Technology (CST) is a privately-owned company with over 400 employees worldwide. We are dedicated to providing innovative research tools that are used to help define mechanisms underlying cell function and disease. Since its inception, CST has become the world leader in the production of the highest quality activation-state and total protein antibodies utilized to expand knowledge of cell signaling pathways. Our mission is to deliver the world's highest quality research tools that accelerate progress in biological research and personalized medicine.